Abstract
Introduction and hypothesis
The Self-Assessment Goal Achievement (SAGA) questionnaire was developed to identify treatment goals and assess goal-achievement in patients with lower urinary tract symptoms (LUTS).
Methods
This study consisted of (1) gathering information on goal setting/attainment concepts, (2) goal elicitation (n = 41 patients with LUTS), (3) cognitive debriefing of draft questionnaire (n = 11), and (4) pilot testing (n = 104).
Results
SAGA consists of baseline (goal-assessment; ranking) and follow-up (goal-achievement) modules. In addition to goals most frequently mentioned, patients can list up to five open goals. Goals most commonly reported as “very important” in pilot testing included reducing urgency (72%), incontinence (65%), and nocturia (64%). Treatment goals spontaneously reported as “very important” were reducing incontinence (45%), nocturia (40%), and frequency (26%).
Conclusions
SAGA may be used to identify treatment goals and assess goal-achievement in patients with LUTS in the clinic and for research (with additional validation). This information may promote patient–physician interaction and help patients establish realistic treatment goals, which may in turn improve treatment adherence and outcomes.
Similar content being viewed by others
Abbreviations
- GAS:
-
Goal attainment scaling
- HRQL:
-
Health-related quality of life
- LUTS:
-
Lower urinary tract symptoms
- OAB:
-
Overactive bladder
- OAB-q:
-
Overactive Bladder Questionnaire
- OAB-S:
-
Overactive Bladder Satisfaction
- PPBC:
-
Patient Perception of Bladder Condition
- SAGA:
-
Self-Assessment Goal Achievement
References
Brubaker L, Chapple C, Coyne KS, Kopp Z (2006) Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment. Urology 68:3–8
Elkadry EA, Kenton KS, FitzGerald MP, Shott S, Brubaker L (2003) Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 189:1551–1557
Benner JS, Nichol MB, Rovner ES, Jumadilova Z, Alvir J, Hussein M et al (2010) Patient-reported reasons for discontinuing overactive bladder medication. BJU Int 105:1276–1282
Marschall-Kehrel D, Roberts RG, Brubaker L (2006) Patient-reported outcomes in overactive bladder: the influence of perception of condition and expectation for treatment benefit. Urology 68(suppl 2A):29–37
Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K (2008) Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int 101:1381–1387
Elinoff V, Bavendam T, Glasser DB, Carlsson M, Eyland N, Roberts R (2006) Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial. Int J Clin Pract 60:745–751
Rosenberg MT (2006) Overactive bladder made ridiculously simple? Int J Clin Pract 60:631–634
Khan MS, Chaliha C, Leskova L, Khullar V (2005) A randomized crossover trial to examine administration techniques related to the Bristol female lower urinary tract symptom (BFLUTS) questionnaire. Neurourol Urodyn 24:211–214
MacDiarmid S, Rosenberg M (2005) Overactive bladder in women: symptom impact and treatment expectations. Curr Med Res Opin 21:1413–1421
Nicolson P, Kopp Z, Chapple CR, Kelleher C (2008) It’s just the worry about not being able to control it! A qualitative study of living with overactive bladder. Br J Health Psychol 13:343–359
Sung VW, Raker CA, Myers DL, Clark MA (2010) Treatment decision-making and information-seeking preferences in women with pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 21:1071–1078
Kiresuk TJ, Lund SH, Larsen NE (1982) Measurement of goal attainment in clinical and health care programs. Drug Intell Clin Pharm 16:145–153
Ashford S, Turner-Stokes L (2006) Goal attainment for spasticity management using botulinum toxin. Physiother Res Int 11:24–34
Hullfish KL, Bovbjerg VE, Gibson J, Steers WD (2002) Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved? Am J Obstet Gynecol 187:88–92
Brubaker L, Kopp Z, Piault E, Trocio J, Evans C, Fitzgerald K, et al (2007) Development of a Self-Assessment Goal Achievement (SAGA) questionnaire in urinary disorders. Paper presented at International Continence Society, Rotterdam, The Netherlands, August 20–24, 2007
Fianu-Jonasson A, Brubaker L, Kelleher C, Khullar V, Bitoun CE, Weinstein D, et al (2009) Understanding Swedish patients’ expectations for treatment of their urinary symptoms. Paper presented at Nordic Urogynecological Association, Reykjavik, Iceland, May 14–16, 2009
Mahajan ST, Elkadry EA, Kenton KS, Shott S, Brubaker L (2006) Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 194:722–728
Payne C, Allee T (2009) Goal achievement provides new insights into interstitial cystitis/painful bladder syndrome symptoms and outcomes. Neurourol Urodyn 28:13–17
Milne JL, Robert M, Tang S, Drummond N, Ross S (2009) Goal achievement as a patient-generated outcome measure for stress urinary incontinence. Health Expect 12:288–300
Lowenstein L, FitzGerald MP, Kenton K, Dooley Y, Templehof M, Mueller ER et al (2008) Patient-selected goals: the fourth dimension in assessment of pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 19:81–84
US Department of Health and Human Services (2009) Patient-reported outcome measures: use in medical product development to support labeling claims. Health Qual Life Outcomes 4:79
Charmaz K (1995) Grounded theory. In: Smith JA, Harre R, Van Langenhove L (eds) Rethinking methods in psychology. Sage, London, pp 27–49
Strauss A, Corbin J (1998) Basics of qualitative research: Techniques and procedures for developing grounded theory. Sage, London
Charmaz K (1991) Good days, bad days: The self in chronic illness and time. Rutgers University Press, New Brunswick
Glaser B, Strauss AL (1967) The constant comparative methods of qualitative analysis. In: Discovery of grounded theory. Aldine de Gruyter, New York, p 101
Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J et al (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11:563–574
Piault E, Evans CJ, Espindle D, Kopp Z, Brubaker L, Abrams P (2008) Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire. Neurourol Urodyn 27:179–190
Krueger KP, Berger BA, Felkey B (2005) Medication adherence and persistence: a comprehensive review. Adv Ther 22:313–356
Shaya FT, Blume S, Gu A, Zyczynski T, Jumadilova Z (2005) Persistence with overactive bladder pharmacotherapy in a Medicaid population. Am J Manag Care 11:S121–S129
Rockwood K, Stolee P, Fox RA (1993) Use of goal attainment scaling in measuring clinically important change in the frail elderly. J Clin Epidemiol 46:1113–1118
Acknowledgement
This study was initiated and sponsored by Pfizer Inc. Editorial support was provided by Simon J. Slater, PhD, at Complete Healthcare Communications, Inc., and was funded by Pfizer Inc.
Conflicts of interest
LB is a consultant and investigator for Pfizer Inc; EP, CJE, and YY are consultants for Pfizer; JB is a consultant and investigator for Pfizer Inc, and an investigator for Bristol-Myers Squibb, Astellas, LLC, Ingenix, and GlaxoSmithKline, plc; VK is a board member, consultant, investigator, and lecturer for Pfizer Inc, and a board member, consultant, and investigator for Astellas, and LLC; TB, ZSK, and JT are employees of Pfizer Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brubaker, L., Khullar, V., Piault, E. et al. Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire. Int Urogynecol J 22, 937–946 (2011). https://doi.org/10.1007/s00192-011-1382-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-011-1382-7